scholarly journals Retaining women in a prenatal care randomized controlled trial in Canada: implications for program planning

2007 ◽  
Vol 7 (1) ◽  
Author(s):  
Suzanne C Tough ◽  
Jodi E Siever ◽  
David W Johnston
Author(s):  
Ebony B. Carter ◽  
Kate Barbier ◽  
Pamela K. Hill ◽  
Alison G. Cahill ◽  
Graham A. Colditz ◽  
...  

Objective This study aimed to determine the feasibility and effectiveness of Diabetes Group Prenatal Care to increase patient engagement in diabetes self-care activities. Study Design A pilot randomized controlled trial was conducted at two sites. Inclusion criteria were English or Spanish speaking, type 2 or gestational diabetes, 22 to 34 weeks of gestational age at first study visit, ability to attend group care at specified times, and willingness to be randomized. Exclusion criteria included type 1 diabetes, multiple gestation, major fetal anomaly, serious medical comorbidity, and serious psychiatric illness. Women were randomized to Diabetes Group Prenatal Care or individual prenatal care. The primary outcome was completion of diabetes self-care activities, including diet, exercise, blood sugar testing, and medication adherence. Secondary outcomes included antenatal care characteristics, and maternal, neonatal, and diabetes management outcomes. Analysis followed the intention-to-treat principle. Results Of 159 eligible women, 84 (53%) consented to participate in the study and were randomized to group (n = 42) or individual (n = 42) prenatal care. Demographic characteristics were similar between study arms. Completion of diabetes self-care activities was similar overall, but women in group care ate the recommended amount of fruits and vegetables on more days per week (5.1 days/week ± 2.0 standard deviation [SD] in group care vs. 3.4 days ± 2.6 SD in individual care; p < 0.01) and gained less weight per week during the study period (0.2 lbs/week [interquartile range: 0–0.7] vs. 0.5 lbs/week [interquartile range: 0.2–0.9]; p = 0.03) than women in individual care. Women with gestational diabetes randomized to group care were 3.5 times more likely to have postpartum glucose tolerance testing than those in individual care (70 vs. 21%; relative risk: 3.5; 95% confidence interval: 1.4–8.8). Other maternal, neonatal, and pregnancy outcomes were similar between study arms. Conclusion Diabetes group care is feasible and shows promise for decreasing gestational weight gain, improving diet, and increasing postpartum diabetes testing among women with pregnancies complicated by diabetes. Key Points


2018 ◽  
Vol 184 (5-6) ◽  
pp. e440-e446 ◽  
Author(s):  
Amy Tanner Tubay ◽  
Kate A Mansalis ◽  
Matthew J Simpson ◽  
Nicole H Armitage ◽  
Gabriel Briscoe ◽  
...  

2020 ◽  
Vol 75 (12) ◽  
pp. 715-716
Author(s):  
Ebony B. Carter ◽  
Kate Barbier ◽  
Pamela K. Hill ◽  
Alison G. Cahill ◽  
Graham A. Colditz ◽  
...  

2014 ◽  
Vol 18 (6) ◽  
pp. 1127-1134 ◽  
Author(s):  
Bright I Nwaru ◽  
Graça Salomé ◽  
Fatima Abacassamo ◽  
Orvalho Augusto ◽  
Julie Cliff ◽  
...  

AbstractObjectiveAssessing the level of adherence and its determinants is important in appraising the overall effectiveness of trials. The present study aimed to evaluate the extent of adherence and its determinants in a pragmatic randomized controlled trial of Fe prophylaxis during pregnancy in Maputo, Mozambique.DesignA pragmatic randomized controlled trial.SettingTwo health centres (1o de Maio and Machava) in Maputo, Mozambique.SubjectsPregnant women (≥12 weeks’ gestation, ≥18 years old, non-high-risk pregnancy; n 4326) attending prenatal care consultations at two health centres were randomized to receive routine Fe (n 2184; 60 mg ferrous sulfate plus 400 μg folic acid daily throughout pregnancy) or selective Fe (n 2142; screening and treatment for anaemia and daily intake of 1 mg folic acid).ResultsThe level of adherence was 79 % for having two or more visits, 53 % for adequate prenatal care and 67 % for complete intake of Fe/folic acid tablets during the trial. The correlation between the adherence measures ranged between 0·151 and 0·739. Adherence did not differ by trial arm, but there were centre differences in adequate prenatal visits and intake of tablets. Older women (>20 years) and those with a history of abortion were more likely to achieve greater adherence, whereas an increased number of previous births decreased the likelihood of adherence. HIV positivity decreased the likelihood of adherence in one trial centre and increased it in the other.ConclusionsThe variation in adherence by trial centre, women’s characteristics and outcome measures suggests that adherence in trials fully depends on participants’ behaviour and can be increased by paying attention to contextual factors.


2016 ◽  
Vol 106 (2) ◽  
pp. 359-365 ◽  
Author(s):  
Jeannette R. Ickovics ◽  
Valerie Earnshaw ◽  
Jessica B. Lewis ◽  
Trace S. Kershaw ◽  
Urania Magriples ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document